| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0008 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.01 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.28 | 0.01 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |